Cargando…

Corrigendum: Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma

Detalles Bibliográficos
Autores principales: Song, Chengli, Wang, Lina, Xu, Qiang, Wang, Kai, Xie, Dan, Yu, Zhe, Jiang, Kui, Liao, Lujian, Yates, John R., Lee, Jiing-Dwan, Yang, Qingkai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445621/
https://www.ncbi.nlm.nih.gov/pubmed/28548101
http://dx.doi.org/10.1038/srep46833
_version_ 1783238932031340544
author Song, Chengli
Wang, Lina
Xu, Qiang
Wang, Kai
Xie, Dan
Yu, Zhe
Jiang, Kui
Liao, Lujian
Yates, John R.
Lee, Jiing-Dwan
Yang, Qingkai
author_facet Song, Chengli
Wang, Lina
Xu, Qiang
Wang, Kai
Xie, Dan
Yu, Zhe
Jiang, Kui
Liao, Lujian
Yates, John R.
Lee, Jiing-Dwan
Yang, Qingkai
author_sort Song, Chengli
collection PubMed
description
format Online
Article
Text
id pubmed-5445621
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-54456212017-05-30 Corrigendum: Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma Song, Chengli Wang, Lina Xu, Qiang Wang, Kai Xie, Dan Yu, Zhe Jiang, Kui Liao, Lujian Yates, John R. Lee, Jiing-Dwan Yang, Qingkai Sci Rep Corrigenda Nature Publishing Group 2017-05-26 /pmc/articles/PMC5445621/ /pubmed/28548101 http://dx.doi.org/10.1038/srep46833 Text en Copyright © 2017, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Corrigenda
Song, Chengli
Wang, Lina
Xu, Qiang
Wang, Kai
Xie, Dan
Yu, Zhe
Jiang, Kui
Liao, Lujian
Yates, John R.
Lee, Jiing-Dwan
Yang, Qingkai
Corrigendum: Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma
title Corrigendum: Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma
title_full Corrigendum: Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma
title_fullStr Corrigendum: Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma
title_full_unstemmed Corrigendum: Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma
title_short Corrigendum: Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma
title_sort corrigendum: targeting bmk1 impairs the drug resistance to combined inhibition of braf and mek1/2 in melanoma
topic Corrigenda
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445621/
https://www.ncbi.nlm.nih.gov/pubmed/28548101
http://dx.doi.org/10.1038/srep46833
work_keys_str_mv AT songchengli corrigendumtargetingbmk1impairsthedrugresistancetocombinedinhibitionofbrafandmek12inmelanoma
AT wanglina corrigendumtargetingbmk1impairsthedrugresistancetocombinedinhibitionofbrafandmek12inmelanoma
AT xuqiang corrigendumtargetingbmk1impairsthedrugresistancetocombinedinhibitionofbrafandmek12inmelanoma
AT wangkai corrigendumtargetingbmk1impairsthedrugresistancetocombinedinhibitionofbrafandmek12inmelanoma
AT xiedan corrigendumtargetingbmk1impairsthedrugresistancetocombinedinhibitionofbrafandmek12inmelanoma
AT yuzhe corrigendumtargetingbmk1impairsthedrugresistancetocombinedinhibitionofbrafandmek12inmelanoma
AT jiangkui corrigendumtargetingbmk1impairsthedrugresistancetocombinedinhibitionofbrafandmek12inmelanoma
AT liaolujian corrigendumtargetingbmk1impairsthedrugresistancetocombinedinhibitionofbrafandmek12inmelanoma
AT yatesjohnr corrigendumtargetingbmk1impairsthedrugresistancetocombinedinhibitionofbrafandmek12inmelanoma
AT leejiingdwan corrigendumtargetingbmk1impairsthedrugresistancetocombinedinhibitionofbrafandmek12inmelanoma
AT yangqingkai corrigendumtargetingbmk1impairsthedrugresistancetocombinedinhibitionofbrafandmek12inmelanoma